<DOC>
	<DOCNO>NCT00004767</DOCNO>
	<brief_summary>OBJECTIVES : I. Assess safety efficacy sodium phenylbutyrate , sodium benzoate , sodium phenylacetate , dietary intervention patient urea cycle disorder .</brief_summary>
	<brief_title>Phase II Study Sodium Phenylbutyrate , Sodium Benzoate , Sodium Phenylacetate , Dietary Intervention Urea Cycle Disorders</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This protocol describe several clinical study pharmacologic dietary management patient urea cycle disorder . Patients carbamyl phosphate synthetase ornithine transcarbamylase deficiency treat low-protein diet , essential amino acid ( neonatal onset disease ) , caloric supplementation , oral sodium phenylbutyrate ( approved prescription drug 11/97 ) , citrulline arginine free base . Patients argininosuccinic acid synthetase deficiency treat low-protein diet , caloric supplementation , oral sodium phenylbutyrate ( approved prescription drug 11/97 ) , arginine free base . Patients argininosuccinic aciduria ( AA ) treat low-protein diet , caloric supplementation , arginine free base . ( Discontinued 11/97 ) Any patient develops hyperammonemia treat intravenous sodium benzoate , sodium phenylbutyrate , arginine hydrochloride ; benzoate phenylbutyrate give patient AA . If ammonium stabilize normal near normal level , intravenous medication gradually replace oral medication . If significant decrease ammonium within 8 hour , patient begin hemodialysis . Concurrent therapy ondansetron , high caloric intake , mannitol elevate intracranial pressure allow . Dietary intravenous nitrogen prohibit . ( Discontinued 11/97 )</detailed_description>
	<mesh_term>Urea Cycle Disorders , Inborn</mesh_term>
	<mesh_term>Metabolism , Inborn Errors</mesh_term>
	<mesh_term>Amino Acid Metabolism , Inborn Errors</mesh_term>
	<mesh_term>4-phenylbutyric acid</mesh_term>
	<mesh_term>Phenylacetic acid</mesh_term>
	<mesh_term>Sodium Benzoate</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Urea cycle deficiency , i.e . : Carbamyl phosphate synthetase deficiency ( CPSD ) Ornithine transcarbamylase deficiency ( OTCD ) Argininosuccinic acid synthetase deficiency ( ASD ) Argininosuccinic aciduria ( AA )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2001</verification_date>
	<keyword>inborn error metabolism</keyword>
	<keyword>rare disease</keyword>
	<keyword>urea cycle disorder</keyword>
</DOC>